+499.5%
MRNA vs CRS
+102.1%
+397.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CRS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.7% | -3.9% | -2.1% |
| 7D | +5.5% | -0.2% | +5.7% | +5.5% |
| 30D | +158.7% | -16.6% | +175.4% | +159.1% |
| 3M | +182.1% | -3.5% | +185.6% | +175.6% |
| 6M | +151.8% | +15.4% | +136.4% | +137.1% |
| YTD | +393.6% | +51.2% | +342.4% | +356.7% |
| 1Y | +499.5% | +98.3% | +401.2% | +454.3% |
| All | +499.5% | +102.1% | +397.4% | +454.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CRS.
Daily Out/Under-Performance
Portfolio return minus CRS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CRS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling